journal
MENU ▼
Read by QxMD icon Read
search

Seminars in Liver Disease

journal
https://www.readbyqxmd.com/read/27997977/regulation-of-hepatocellular-fatty-acid-uptake-in-mouse-models-of-fatty-liver-disease-with-and-without-functional-leptin-signaling-roles-of-nfkb-and-srebp-1c-and-the-effects-of-spexin
#1
Jasmine F Ge, J L Walewski, D Anglade, P D Berk
The processes causing increased hepatic triglycerides (TGs) in mouse models of hepatic steatosis (HS) due to high fat diet (HFD)-induced obesity (DIO), EtOH consumption, or obesity mutations (ob/ob, db/db) are uncertain. This report summarizes two studies. Study 1 focused on regulation by five transcription factors (TFs) (NfKb, Srebp-lc, AMPK, PPARα, PPARγ) of seven, much-studied hepatic long-chain fatty acid (LCFA) transporters (FABPpm, CD36, FATPl, FATP2, FATP4, FATP5, & Caveolin-1 [CAV-1]), and expression of genes for enzymes of LCFA synthesis (SCD-1, FASN) in mice with HS from various causes...
September 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27997976/the-microbiome-what-will-the-future-hold
#2
Howard Paul Monsour, Eamonn M M Quigley
Current research on the human microbiome has opened our eyes to the intimate relationship that we have with the bacteria that populate our gastrointestinal tract and its potential relationship to health and disease. To date, clinical research on the microbiome has identified intriguing associations between an altered microbiome and disease states, but proven therapeutic applications have been very limited. The ingestion of prebiotics, probiotics, and/or synbiotics is appealing to the general public and has significant commercial value, but as yet, solid evidence for clinical efficacy in liver disease has been lacking due, in large part, to the paucity of high-quality clinical trials...
September 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27997975/primary-biliary-cirrhosis-and-the-microbiome
#3
Eamonn M M Quigley
Primary biliary cirrhosis is a rather uncommon, slowly progressive, cholestatic liver disease that predominantly affects middle-aged women. Apart from the changes in the gut microbiome that have been described in liver disease in general, little is known of the composition of the microbiome in primary biliary cirrhosis. Nevertheless, epidemiological, clinical, and some experimental evidence points to the possible role of a bacterium (or bacteria) in the initiation of the autoimmune process that leads to the development of this unique clinical phenotype...
September 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27997974/the-microbiome-and-primary-sclerosing-cholangitis
#4
Ahmad H Ali, Elizabeth J Carey, Keith D Lindor
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with detrimental sequela. In many patients, PSC progresses to end-stage liver disease and hepatobiliary cancer. There is no medical therapy that is proven to halt or reverse the progression of PSC. Approximately 70 to 80% of PSC patients have inflammatory bowel disease, usually ulcerative colitis. The etiology of PSC is poorly understood. Several lines of evidence suggest that the intestinal microbiota plays an important role in the etiopathogenesis of PSC...
September 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27997973/bidirectional-communication-between-liver-and-gut-during-alcoholic-liver-disease
#5
Peter Stärkel, Bernd Schnabl
Alcoholic liver disease is a major medical burden. Alcohol abuse is the cause for end-stage liver disease in approximately 50% of all patients with cirrhosis. Chronic alcohol consumption is associated with changes in the composition of the intestinal microbiota and gut barrier dysfunction. The portal vein is the major communication route between the intestine and the liver. Increased intestinal permeability allows microbial components, bacteria, and metabolites to translocate to the liver. The liver communicates with the intestine via mediators in the systemic circulation and the biliary system...
September 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27997972/changes-in-the-microbiome-in-cirrhosis-and-relationship-to-complications-hepatic-encephalopathy-spontaneous-bacterial-peritonitis-and-sepsis
#6
Jatinder Lachar, Jasmohan S Bajaj
Chronic liver disease with progression to decompensated cirrhosis and its associated complications, including hepatic encephalopathy, spontaneous bacterial peritonitis, and sepsis, is a leading cause of mortality and morbidity. The pathophysiology of decompensated cirrhosis, which is being intensively studied, leads to the development of gut microbiome changes causing dysbiosis. This is likely related to altered bile acid composition, with a subsequent increase in the relative abundance of potentially pathogenic bacteria that contributes to hepatic encephalopathy and leads to their translocation and the development of spontaneous bacterial peritonitis and bacteremia...
September 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27997971/microbiome-host-immune-system-interactions
#7
Sylwia Smolinska, Liam O'Mahony
The intestinal immune system recognizes and responds to the vast diversity of microbes present within the gut. Highly sophisticated cellular and molecular networks are continuously coordinated to tolerate the presence of a large number and diversity of bacteria on mucosal surfaces. Different types of bacteria induce different immune responses, and bacterial metabolism of dietary factors generates metabolites that have significant effects on host immune responses. Dendritic cells, epithelial cells, innate lymphoid cells, T-regulatory cells, effector lymphocytes, natural killer T cells, and B-cell responses can all be influenced by the microbiome...
September 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27997970/the-metabolic-role-of-the-microbiome-implications-for-nafld-and-the-metabolic-syndrome
#8
Eamonn M M Quigley, Ahmed Abu-Shanab, Eileen F Murphy, Catherine Stanton, Howard P Monsour
Nonalcoholic fatty liver disease (NAFLD) has rapidly emerged as one of the most prevalent liver diseases worldwide and is set to achieve virtually epidemic proportions if current trends in obesity continue. A considerable volume of data from animal experiments has revealed the magnitude of the metabolic contribution of the gut microbiome and how a disordered microbial population could contribute to the development of obesity and its complications, including NAFLD. Although considerable progress has been made in developing a role for the microbiome in NAFLD and nonalcoholic steatosis (NASH), there are still many issues to be resolved, including the nature and location of the altered microbiome (i...
September 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27997969/studying-the-microbiome-omics-made-accessible
#9
Paul W O'Toole, Burkhardt Flemer
The term microbiome refers to the collection of microbes or microbial genes in a specified location or clinical sample. Identifying micro-organisms has historically relied upon bacteriological culture, which is time consuming and difficult to effectively implement. The recent adaptation of culture-independent techniques for profiling microbial communities, allied with next-generation massively parallel DNA sequencing, allows clinician scientists to determine the entire microbial content of a specimen to a forensic level of detail within 48 hours...
September 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27997968/the-microbiome-and-the-liver-the-basics
#10
David W Victor, Eamonn M M Quigley
The relationships between the microbiota and other aspects of normal human biology continue to be explored. Indeed, the volume of information relating to the interplay between the host and the microbiota has grown exponentially-especially with the advent of ever-improving techniques for rapidly sequencing and identifying bacterial populations and their functions. The gut is initially sterile at birth and colonization and dynamic changes occur during infancy and early childhood in order to establish a mature microbiome...
September 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27997967/the-last-hurrah
#11
Paul D Berk
No abstract text is available yet for this article.
September 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27466798/the-treatment-of-igg4-related-diseases-in-the-hepatobiliary-pancreatic-system
#12
Terumi Kamisawa, Sawako Kuruma, Kazuro Chiba
An accurate diagnosis should be made before treatment of autoimmune pancreatitis and immunoglobulin G4-related sclerosing cholangitis. Once a diagnosis has been established, steroids are the standard therapy and symptoms are the major indications. Before steroid therapy, obstructive jaundice and hyperglycemia should be controlled. An initial dose of 0.6 mg/kg/d of oral prednisolone is administered for 2 to 4 weeks, and is gradually tapered over 2 to 3 months. After steroid therapy has begun, blood and imaging tests are performed periodically...
August 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27466797/igg4-related-kidney-disease-and-igg4-related-retroperitoneal-fibrosis
#13
Mitsuhiro Kawano, Kazunori Yamada
Immunoglobulin G4-related kidney disease (IgG4-RKD) is the collective name encompassing renal parenchymal and renal pelvic lesions. The hallmark of renal parenchymal lesions of IgG4-related disease is plasma cell-rich tubulointerstitial nephritis with numerous IgG4-positive plasma cells and characteristic fibrosis. In addition, glomerular lesions are sometimes present, with membranous glomerulonephritis being the most common. Although IgG4-RKD shows good responsiveness to corticosteroid therapy, follow-up imaging studies have revealed that partial cortical scars persist when the start of therapy is delayed...
August 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27466796/igg4-related-disease-in-organs-other-than-the-hepatobiliary-pancreatic-system
#14
Motohisa Yamamoto, Hiroki Takahashi
Immunoglobulin G4-related disease (IgG4-RD) is a new disease entity that was established in this century. It is a systemic and chronic inflammatory disorder. Autoimmune pancreatitis is a representative condition, but there is clearly involvement from other organs, including the kidneys, the retroperitoneal cavity, the lungs, and the thyroid, lacrimal, salivary, pituitary, and prostate glands. To aid in the resolution of the numerous issues related to IgG4-RD, the authors established a registry system of patients in multicenter institutes with IgG4-RD-the SMART registry...
August 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27466795/current-concepts-and-diagnosis-of-igg4-related-pancreatitis-type-1-aip
#15
Shigeyuki Kawa
Although now considered to be a member of the systemic entity of immunoglobulin G4- (IgG4-) related disease, IgG4-related pancreatitis is generally referred to as type 1 autoimmune pancreatitis (AIP). Type 1 AIP was established based on a pathological background of lymphoplasmacytic sclerosing pancreatitis, high serum IgG4 concentration, and abundant IgG4-bearing plasma cell infiltration. The characteristic clinical features of type 1 AIP, such as elderly male preponderance, obstructive jaundice, and mass-forming lesions in the pancreas, often mimic those of pancreatic cancer...
August 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27466794/the-pathology-of-igg4-related-disease-in-the-bile-duct-and-pancreas
#16
Yoh Zen
Immunoglobulin G4-related disease (IgG4-RD) in the pancreatobiliary system manifests as sclerosing cholangitis (SC), hepatic inflammatory pseudotumors, and type 1 autoimmune pancreatitis (AIP). The pathology of IgG4-RD involves an inflammatory process and fibrogenic pathway, the combination of which damages the affected organs. Fibroinflammatory injury is characterized by three microscopic findings: a diffuse lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells, obliterative phlebitis, and storiform fibrosis...
August 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27466793/histopathology-of-igg4-related-autoimmune-hepatitis-and-igg4-related-hepatopathy-in-igg4-related-disease
#17
Yasuni Nakanuma, Yoji Ishizu, Yoh Zen, Kenichi Harada, Takeji Umemura
Immunoglobulin G4-related disease (IgG4-RD) is a systemic disease involving many organs; it includes IgG4-related sclerosing cholangitis and inflammatory pseudotumor in the hepatobiliary system. Two types of hepatic parenchymal involvement have been reported in IgG4-RD: IgG4-related autoimmune hepatitis (AIH) and IgG4-hepatopathy. Moreover, only three cases of IgG4-related AIH have been reported. Immunoglobulin G4-related AIH is clinicopathologically similar to AIH, except for an elevated serum IgG4 level and heavy infiltration of IgG4-positive plasma cells in the liver tissue...
August 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27466792/igg4-related-sclerosing-cholangitis
#18
Takahiro Nakazawa, Shuya Shimizu, Itaru Naitoh
More men than women develop immunoglobulin G4-related sclerosing cholangitis (IgG4-SC). Age at clinical onset is significantly older in patients with IgG4-SC. Patients with IgG4-SC appear similar to those with cholangiocarcinoma and primary sclerosing cholangitis (PSC). The association between IgG4-SC and autoimmune pancreatitis (AIP) is useful for the diagnosis of IgG4-SC. However, some IgG4-SC cases are isolated from AIP and are difficult to diagnose. The authors focus on three distinct features of IgG4-SC...
August 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27466791/the-immunobiology-of-immunoglobulin-g4
#19
Laura C Lighaam, Theo Rispens
Human immunoglobulin G4 (IgG4) antibodies are in many ways unusual. In this review, an overview is given of the structural and functional aspects of IgG4 antibodies, the consequences of IgG4 antibody formation in various disease settings, and the factors involved in the regulation of IgG4 responses. Unlike most IgG antibodies, IgG4 antibodies exist in a dynamic equilibrium with other IgG4 antibodies, continuously exchanging half-molecules resulting in effectively monovalent antibodies that cannot cross-link...
August 2016: Seminars in Liver Disease
https://www.readbyqxmd.com/read/27466790/the-geoepidemiology-and-clinical-aspects-of-igg4-related-disease
#20
Kazushige Uchida, Toshihiro Tanaka, M Eric Gershwin, Kazuichi Okazaki
Immunoglobulin G4-related disease (IgG4-RD) is a recently described systemic inflammatory disease characterized by increased serum IgG4 concentrations, lymphoplasmacytic infiltrations, storiform fibrosis, and obliterative phlebitis. However, although IgG4-RD has become increasingly recognized, the number of patients with IgG4-RD remains unclear. Data from several studies indicate that patients who have a T-helper type 2 (Th2-) dominant immune response, which leads to the hyperproduction of Th2 cytokines, then progress to IgG4-RD...
August 2016: Seminars in Liver Disease
journal
journal
20238
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"